Verona Pharma plc (VRNA) Misses Q2 EPS by 6c
Verona Pharma plc (NASDAQ: VRNA) reported Q2 EPS of ($0.11), $0.06 worse than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.
Verona Pharma plc (NASDAQ: VRNA) reported Q2 EPS of ($0.11), $0.06 worse than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.